DeepMed Research

Imperial College London

🇧🇪Belgium

Country: 🇧🇪Belgium

Ownership: Private

Established: 1907-07-08

Employees: 5K

Market Cap: -

Website: http://www.imperial.ac.uk

Clinical Trials

Mechanisms of Multi-organ Failure in COVID-19

Recruiting

Conditions: COVID

Interventions: Other: no intervention-mechanistic study

First Posted Date: 2020-05-22

Last Posted Date: 2024-03-08

Lead Sponsor: Imperial College London

Target Recruit Count: 120

Registration Number: NCT04399603

Locations: 🇬🇧
Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom
🇬🇧
Imperial College NHS Trust, London, United Kingdom

PROState Pathway Embedded Comparative Trial

Completed

Conditions: Non-metastatic Prostate Cancer
Metastatic Prostate Cancer
Prostate Adenocarcinoma
Metastatic Prostate Carcinoma in the Soft Tissue
Prostate Cancer Metastatic
Prostate Cancer

First Posted Date: 2020-05-22

Last Posted Date: 2022-09-23

Lead Sponsor: Imperial College London

Target Recruit Count: 139

Registration Number: NCT04400656

Locations: 🇬🇧
West Middlesex University Hospital, Isleworth, Middlesex, United Kingdom
🇬🇧
Ashford & St Peter's Hospitals (ASPH) NHS Foundation Trust, Chertsey, Surrey, United Kingdom
🇬🇧
Imperial College Healthcare NHS Trust, London, United Kingdom

COVID-19 and Cancer Patients

Conditions: Cancer
Sars-CoV2

First Posted Date: 2020-05-19

Last Posted Date: 2022-07-15

Lead Sponsor: Imperial College London

Target Recruit Count: 1000

Registration Number: NCT04393974

Locations: 🇬🇧
Imperial College Healthcare NHS Trust, London, United Kingdom

TheraSphere Selective Internal Radiation Therapy (SIRT) as Treatment for Neuroendocrine Tumours With Liver Mets

Phase 2

Recruiting

Conditions: Liver Metastases
Neuroendocrine Tumors

Interventions: Radiation: TheraSpheres Selective Internal Radiation Therapy (SIRT)

First Posted Date: 2020-04-27

Last Posted Date: 2022-03-09

Lead Sponsor: Imperial College London

Target Recruit Count: 24

Registration Number: NCT04362436

Locations: 🇬🇧
Imperial College NHS Trust, London, United Kingdom

Itacitinib in Advanced Hepatocellular Carcinoma

Phase 1

Active, not recruiting

Conditions: Advanced Hepatocellular Carcinoma

Interventions: Drug: Itacitinib (INCB039110)

First Posted Date: 2020-04-24

Last Posted Date: 2023-02-14

Lead Sponsor: Imperial College London

Target Recruit Count: 24

Registration Number: NCT04358185

Locations: 🇬🇧
Imperial College Healthcare NHS Trust, London, United Kingdom

Axitinib Monotherapy With Early Dynamic Contrast Enhanced Ultrasound Monitoring in Chemorefractory Third Line Metastatic Colorectal Cancer

Phase 2

Completed

Conditions: Colorectal Cancer

Interventions: Drug: Placebo
Drug: Axitinib

First Posted Date: 2020-04-21

Last Posted Date: 2020-04-21

Lead Sponsor: Imperial College London

Target Recruit Count: 52

Registration Number: NCT04355156

Locations: 🇬🇧
Imperial College Healthcare NHS Trust, London, United Kingdom

Remote Monitoring Use In Cases Of Suspected COVID-19 (Coronavirus)

Completed

Conditions: Coronavirus

First Posted Date: 2020-04-07

Last Posted Date: 2024-10-08

Lead Sponsor: Imperial College London

Target Recruit Count: 15

Registration Number: NCT04337489

Locations: 🇬🇧
Imperial College London, London, United Kingdom

Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.

Not Applicable

Terminated

Conditions: COVID-19

Interventions: Drug: Aspirin 75mg
Drug: Clopidogrel 75mg
Drug: Rivaroxaban 2.5 MG
Drug: Atorvastatin 40mg
Drug: Omeprazole 20mg

First Posted Date: 2020-04-03

Last Posted Date: 2023-01-18

Lead Sponsor: Imperial College London

Target Recruit Count: 320

Registration Number: NCT04333407

Locations: 🇬🇧
Charing Cross Hospital, London, United Kingdom

A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).

Phase 2

Recruiting

Conditions: HIV/AIDS and Infections

Interventions: Drug: Investigational Medicinal Product

First Posted Date: 2020-03-24

Last Posted Date: 2024-04-17

Lead Sponsor: Imperial College London

Target Recruit Count: 72

Registration Number: NCT04319367

Locations: 🇬🇧
Manchester University NHS Foundation Trust, Manchester, United Kingdom
🇬🇧
Barts Health NHS Trust, London, United Kingdom
🇩🇰
Aarhus University Hospital, Aarhus, Denmark

and more 9 locations

The Evaluation of Tomographic 3D Ultrasound for the Assessment of Vascular Pathology

Completed

Conditions: Carotid Artery Plaque

Interventions: Device: 3D Imaging.

First Posted Date: 2020-03-23

Last Posted Date: 2023-01-25

Lead Sponsor: Imperial College London

Target Recruit Count: 75

Registration Number: NCT04318171

Locations: 🇬🇧
Imperial College London, London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy